An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study
- Conditions
- AnemiaArthroplasty, Replacement, KneeArthroplasty, Replacement, Hip
- Interventions
- Drug: Iron-III Isomaltoside 1000Other: Standard Care
- Registration Number
- NCT02385383
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
This observational study follows a cohort of patients scheduled for elective hip- or knee surgery but has preoperative anemia and are treated with Intravenous (IV) iron prior to surgery according to a recently introduced standardized treatment protocol at 6 high-volume surgical centres.
- Detailed Description
Patients presenting with preoperative anaemia prior to hip and knee arthroplasty has a high risk of receiving allogeneic blood transfusion and anaemia has been associated with increased postoperative morbidity and mortality. While IV-iron administration may raise Hb prior to surgery, existing guidelines for addressing and treating preoperative anaemia is not widely implemented for patients scheduled for elective total joint arthroplasty (TJA) in Denmark. In addition, causes of preoperative anaemia and the efficacy of preoperative IV-iron administration has not been sufficiently evaluated in elective TJA.
This is a observational follow-up study among 6 Danish high volume surgical centres that has recently introduced a standardized anaemia screening and treatment protocol for patients with preoperative anaemia scheduled for total hip- or knee arthroplasty.
Patients with iron deficiency anaemia or anaemia of chronic inflammation receive infusion of IV-iron (Monofer) 4 weeks prior to surgery as a part of the standard operating procedure on the department.
The aim of this follow up study is to evaluate changes in Haemoglobin concentration, transfusion rate and postoperative morbidity in this cohort.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- Age > 18 years
- Scheduled for elective primary hip- or knee arthroplasty
- Preoperative hemoglobin < 13 g/dl (males) or < 12 g/dl (females)
- Included in the departments treatment protocol for preoperative anemia
- Cronic transfusion need
- Not able to give consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with preoperative anemia following treatment protocol Iron-III Isomaltoside 1000 Patients with preoperative anemia according to the WHO definition and treated with a protocol of Iitravenous iron prior to surgery Patients with preoperative anemia - Historical control Standard Care Cohort of preoperative anemic patients from the Lundbeckcentre Database. Serving as a historical control
- Primary Outcome Measures
Name Time Method Transfusion Rate From date of admission to date of discharge (up to 30 days) Blood transfusion (yes/no) during the entire hospital stay
- Secondary Outcome Measures
Name Time Method Classification of preoperative anemia 4 weeks prior to surgery (baseline) Change in hemoglobin concentration From date of preoperative blood sampling (baseline) to date of admission (Up to 4 weeks) The change in Hb from the time of preoperative blood sampling to Hb sampled on the date of admission
No. of red blood cell units administered per patient From date of admission to date of discharge (up to 30 days) No of blood units administered during the entire hospital stay
Length of Hospital stay From date of admission to Date of discharge (up to 30 days) Postoperative complications and readmissions From date of surgery up to 90 days after surgery
Trial Locations
- Locations (6)
Bisbebjerg Hospital, Dept. of orthopedic surgery
🇩🇰Copenhagen NV, Denmark
Farsø Sygehus
🇩🇰Farsø, Denmark
Gentofte Hospital, Dept. of orthopedic surgery
🇩🇰Hellerup, Denmark
Hvidovre Hospital, Department of orthopaedic surgery
🇩🇰Hvidovre, Denmark
Vejle Sygehus, Dept. of orthopedic surgery
🇩🇰Vejle, Denmark
Viborg Sygehus, Dept. of orthopedic surgery
🇩🇰Viborg, Denmark